| RS1367115848 |
F7
|
Health Risk |
Likely pathogenic |
Factor VII deficiency, Congenital factor VII deficiency |
| RS1367121673 |
ACAT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS1367142675 |
TRIT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Mitochondrial disease |
| RS1367145848 |
SYNJ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset Parkinson disease 20, Developmental and epileptic encephalopathy |
| RS1367201083 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Cystic fibrosis |
| RS1367206658 |
SLC2A10
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Arterial tortuosity syndrome |
| RS1367210165 |
NEBL
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS1367214521 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS1367215268 |
STRA6
|
Health Risk |
Pathogenic |
Matthew-Wood syndrome, Matthew-Wood syndrome |
| RS1367224902 |
CHRNG
|
Health Risk |
Likely pathogenic |
— |
| RS1367225717 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1367232226 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS1367238054 |
KAT6A
|
Health Risk |
Conflicting classifications of pathogenicity |
KAT6A-related disorder, KAT6A-related disorder |
| RS1367262797 |
AGRN
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 8, Neurodevelopmental disorder |
| RS1367268677 |
NEK8
|
Health Risk |
Pathogenic |
Renal-hepatic-pancreatic dysplasia 2, Renal-hepatic-pancreatic dysplasia 2 |
| RS1367275342 |
CC2D2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1367289835 |
TH
|
Health Risk |
Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1367292809 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Inborn genetic diseases |
| RS1367335682 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS1367336734 |
FGFR3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1367341478 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1367344104 |
PEX6
|
Health Risk |
Likely pathogenic |
Heimler syndrome 2, Heimler syndrome 2 |
| RS1367350631 |
NPHP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Nephronophthisis |
| RS1367352545 |
KRT1
|
Health Risk |
Likely pathogenic |
— |
| RS1367362454 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS1367364158 |
GBE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type IV |
| RS1367385862 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1367396955 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS1367402208 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1367402633 |
MTR
|
Health Risk |
Likely pathogenic |
— |
| RS1367425262 |
CDK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS1367426610 |
MYOM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1367439751 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Renal cell carcinoma |
| RS1367444910 |
LAMB2
|
Health Risk |
Pathogenic |
Pierson syndrome, LAMB2-related infantile-onset nephrotic syndrome |
| RS1367454316 |
SZT2
|
Health Risk |
Pathogenic |
SZT2-related disorder, SZT2-related disorder |
| RS1367462378 |
GALNS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS1367505804 |
BRPF1
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with dysmorphic facies and ptosis, Intellectual developmental disorder with dysmorphic facies and ptosis |
| RS1367514850 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS1367522452 |
BCOR
|
Health Risk |
Pathogenic |
Oculofaciocardiodental syndrome, Oculofaciocardiodental syndrome |
| RS1367528939 |
ELAC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 17, Combined oxidative phosphorylation defect type 17 |
| RS1367543388 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS1367545625 |
MYRF
|
Health Risk |
Pathogenic |
Cardiac-urogenital syndrome, Cardiac-urogenital syndrome |
| RS1367550528 |
SMARCAL1
|
Health Risk |
Likely pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS1367567191 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS1367585890 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1367615271 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1367617850 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1367633896 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1367661704 |
GAMT
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral creatine deficiency syndrome, Deficiency of guanidinoacetate methyltransferase |
| RS1367668493 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1367674744 |
AP4B1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 47, Hereditary spastic paraplegia 47 |
| RS1367685651 |
ADGRG1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1367689213 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1 |
| RS1367694162 |
EVC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1367720345 |
SATB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1367725176 |
KAT6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS1367736540 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1367740488 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1367746167 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1367759005 |
KMT2B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1367760687 |
FLNC
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 5, Hypertrophic cardiomyopathy 26 |
| RS1367761716 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1367777385 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS1367784766 |
TNNT3
|
Health Risk |
Conflicting classifications of pathogenicity |
Distal arthrogryposis type 2B1, Distal arthrogryposis type 2B1 |
| RS1367797614 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1367809298 |
BICD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia, Autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures |
| RS1367820520 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1367822001 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1367823627 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1367846935 |
BCS1L
|
Health Risk |
Pathogenic |
— |
| RS1367858373 |
RTEL1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS1367861495 |
ACTG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Baraitser-winter syndrome 2, Autosomal dominant nonsyndromic hearing loss 20 |
| RS1367867218 |
PCCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1367899236 |
CEP290
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1367905743 |
AEBP1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic-like |
| RS1367906290 |
COL4A4
|
Health Risk |
Pathogenic |
Hematuria, Hematuria |
| RS1367927635 |
BBS2
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 2, Bardet-Biedl syndrome |
| RS1367958450 |
DEGS1
|
Health Risk |
Likely pathogenic |
Leukodystrophy, hypomyelinating |
| RS1368001965 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1368005133 |
NF1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1368013631 |
FIG4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4J, Charcot-Marie-Tooth disease |
| RS1368027694 |
MCOLN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucolipidosis type IV, Lisch epithelial corneal dystrophy |
| RS1368031096 |
GSTZ1
|
Health Risk |
Likely pathogenic |
Maleylacetoacetate isomerase deficiency, Maleylacetoacetate isomerase deficiency |
| RS1368074390 |
OCA2
|
Health Risk |
Pathogenic |
OCA2-related disorder, OCA2-related disorder |
| RS1368075571 |
ARID2
|
Health Risk |
Pathogenic |
— |
| RS1368086969 |
SCARF2
|
Health Risk |
Likely pathogenic |
Van den Ende-Gupta syndrome, Van den Ende-Gupta syndrome |
| RS1368090073 |
OCRL
|
Health Risk |
Conflicting classifications of pathogenicity |
Lowe syndrome, Thyroid cancer |
| RS1368099067 |
AMT
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1368101093 |
TRIP11
|
Health Risk |
Pathogenic |
Achondrogenesis, type IA |
| RS1368105372 |
NPHP4
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis, Nephronophthisis 4 |
| RS1368119296 |
MTO1
|
Health Risk |
Likely pathogenic |
Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency, Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency |
| RS1368132952 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 5 |
| RS1368134215 |
COL7A1
|
Health Risk |
Pathogenic |
Epidermolysis bullosa dystrophica, Recessive dystrophic epidermolysis bullosa |
| RS1368171478 |
MMUT
|
Health Risk |
Likely pathogenic |
— |
| RS1368182301 |
PYGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type VI |
| RS1368193719 |
EVC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1368205104 |
SZT2
|
Health Risk |
Likely pathogenic |
— |
| RS1368221807 |
GDF6
|
Health Risk |
Conflicting classifications of pathogenicity |
Microphthalmia, isolated |
| RS1368222485 |
CHD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1368238343 |
EIF2B5
|
Health Risk |
Conflicting classifications of pathogenicity |
Vanishing white matter disease, Vanishing white matter disease |